Showing results (741-750 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|December 17, 2008
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumorsElaine T Lam, Cindy L O'Bryant, Michele Basche, et al.
Molecular Cancer Therapeutics|December 17, 2008
Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolismBruno Payré, Philippe de Medina, Nadia Boubekeur, et al.
Molecular Cancer Therapeutics|December 17, 2008
A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}Shan Hua Li, Dong Hoon Shin, Yang-Sook Chun, et al.
Molecular Cancer Therapeutics|December 17, 2008
Overexpression of the dual specificity phosphatase, Cdc25C, confers sensitivity on tumor cells to doxorubicin-induced cell deathShohreh Varmeh, James J Manfredi
Molecular Cancer Therapeutics|December 17, 2008
Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cellsLijun Shen, Wing-Yan Au, Kai-Yau Wong, et al.
Molecular Cancer Therapeutics|December 17, 2008
Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvantYanping Wang, Xiang-Yang Wang, John R Subjeck, et al.
Molecular Cancer Therapeutics|October 15, 2008
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell linesPhilip L Lorenzi, Jenny Llamas, Michele Gunsior, et al.
Molecular Cancer Therapeutics|October 15, 2008
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signalingScott M Wilhelm, Lila Adnane, Philippa Newell, et al.
Molecular Cancer Therapeutics|October 15, 2008
Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sonia C Maggio, et al.
Molecular Cancer Therapeutics|October 15, 2008
Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesisAjaikumar B Kunnumakkara, Haruyo Ichikawa, Preetha Anand, et al.
Pageof 599